The Dukes’ CRC stage specific analyses identified 6 target proteins (IFN-G, IL-4, IL-8, MCP-1, MIP-1 and PDGF-BB) that were each significantly elevated in stage D plasmas compared with healthy unaffected controls (P < 0.05) (Table 3). This evidence concerns the gene CCL2 and colorectal carcinoma.